Emeren Group

SOL · NYSE

Price unavailable right now.

No price history for this range.

Key indicators

SOL profitability and balance sheet ratios

EPS -$0.0065 in Q3 FY25, down 169.1% on a year earlier.

EPS by quarter
PeriodEPS
Q4 FY23-$0.0041
Q1 FY24-$0.0111
Q2 FY24$0.0008
Q3 FY24$0.0094
Q4 FY24-$0.023
Q1 FY25$0.03
Q2 FY25$0.0283
Q3 FY25-$0.0065

Where the money went

Q3 FY25, from revenue to net income

Emeren Group brought in $15.6M of revenue in Q3 FY25, +21.6% on a year earlier. It made a net loss of $0.3M.

Revenue
$15.6M
Costs, expenses and taxes
$16.0M
Net income
−$0.3M
Net margin
-2.1%

Income statement

Revenue and profit by reporting period

Revenue
Net income
SOL income statement, quarterly
Line itemQ1 FY25Q2 FY25Q3 FY25
Revenue$8.2M$12.9M$15.6M
Gross profit$3.2M$6.7M$9.5M
Operating income−$1.3M−$30.4M$8.1M
Net income$1.5M$1.5M−$0.3M
Diluted EPS$0.03$0.03-$0.01

Balance sheet

What the company owns and owes at period end

Total assets
Total liabilities
SOL balance sheet, quarterly
Line itemMar 2025Jun 2025Sep 2025
Total assets$464.9M$442.9M$449.5M
Total liabilities$160.9M$132.3M$139.1M
Shareholder equity$304.1M$310.5M$310.4M
Cash and short-term investments$52.9M$46.6M$84.6M
Total debt$58.0M$62.8M$68.6M

Cash flow

Cash in and out from operations, investing and financing

Operating
Investing
Financing
SOL cash flow, quarterly
Line itemQ1 FY25Q2 FY25Q3 FY25
Operating cash flow−$1.9M$2.3M$34.1M
Investing cash flow−$2.1M−$1.7M−$1.3M
Financing cash flow$13.2M$1.0M$5.0M
Capital expenditure−$2.7M−$2.1M−$1.5M
Free cash flow−$4.5M$0.1M$32.6M

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.